Swati Tomar

@aiims.edu

Assistant Professor, Department of Obstetrics and Gynaecology
All India Institute of Medical Sciences, New Delhi

Swati Tomar


                        Download Compact PDF  
https://researchid.co/swatitomar

EDUCATION

MBBS (Gold Medalist) Dr MGR Medical University, Chennai, Tamil Nadu, India
MD (Obstetrics and Gynaecology), All India Institute of Medical Sciences (AIIMS), New Delhi, India
Diplomate of National Board (DNB), National Board of Examinations in Medical Sciences, India

RESEARCH, TEACHING, or OTHER INTERESTS

Obstetrics and Gynecology, Oncology, Multidisciplinary
8

Scopus Publications

Scopus Publications

  • Navigating Arterio-venous Malformations in Placental Site Trophoblastic Tumour: Dilemmas and Successful Management
    Swati Tomar, Suvidya Singh, Sandeep R. Mathur, M. D. Ray, Sachin Khurana, Neena Malhotra, Seema Singhal
    Indian Journal of Gynecologic Oncology, 2026
  • Successful Resection of Abdominal Wall Endometriosis (AWE) at Caesarean Scar Through Minimally Invasive Route- Description of a Surgical Procedure
    Reeta Mahey, Swati Tomar, Ayushi Negi, Aarti Sharma
    Journal of Minimally Invasive Gynecology, 2026
  • Comparison of Three Techniques for Skin Closure in Caesarean Delivery (Absorbable Subcuticular Sutures, Non-absorbable Nylon Sutures, Surgical Staplers): A Randomized Controlled Trial
    Shreya S. Kushwaha, Seema Singhal, Soniya Dhiman, Sunesh Kumar, Kallol K. Roy, Jyoti Meena, Swati Tomar
    Journal of Obstetrics and Gynecology of India, 2025
  • Small-Cell Neuroendocrine Carcinoma of the Cervix at 21 Weeks of Gestation: Multidisciplinary Management and Outcomes
    Saroj Rajan, Swati Tomar, Chandrima Ray, Sushmita Pathy, Sachin Khurana, Smita Manchanda, Sandeep Mathur, Neerja Bhatla, Neena Malhotra, Seema Singhal
    Journal of Obstetrics and Gynecology of India, 2025
  • Patterns of care for vulvar cancer and insights from revised FIGO staging: a retrospective study
    Seema Singhal, Daya Nand Sharma, Sandeep Mathur, Swati Tomar, Jyoti Meena, Anju Singh, Neerja Bhatla
    World Journal of Surgical Oncology, 2024
    BACKGROUND: The objective of this study was to evaluate the clinicopathological characteristics and patterns of care among women diagnosed with vulvar malignancy at a tertiary care teaching institute. Additionally, the study aimed to analyse the implications of revised FIGO staging system on stage shift and patient outcomes. METHODS: A retrospective observational study was conducted, wherein hospital records of biopsy-proven cases of vulvar cancers managed over a period of 10 years were comprehensively reviewed. The assignment of FIGO staging was performed utilizing both 2009 and 2021 FIGO staging systems for comparative analysis. Statistical analysis was performed using STATA version 17. Survival curves were constructed using the Kaplan-Meier method, with differences assessed using the log-rank test. Additionally, multivariable analysis was conducted using the Cox proportional hazard model. RESULTS: A total of 82 cases meeting the inclusion criteria were enrolled in the study. Management patterns varied widely, with the majority undergoing surgery (73.2%), followed by definitive radiotherapy with or without chemotherapy (10.9%), neoadjuvant radiotherapy and subsequent surgery (4.9%), and palliative care (10.9%). Post-operative radiotherapy was administered in 31.7% of cases. The disease-specific recurrence rate was found to be 32.9%, and the mortality rate was 30.5%. The median Disease-Free Survival (DFS) was 17 months (interquartile range [IQR]: 1-36 months), while the Overall Survival (OS) was 27 months (IQR: 9-52 months). Upon application of the 2021 staging system, a stage shift was observed in 18% of cases of advanced vulvar cancer. The 3-year DFS and OS were reduced for stage IIIA and stage IVA, while showing improvement for stage IIIB. CONCLUSIONS: The revised FIGO 2021 staging system offers enhanced simplicity in its application within clinical practice and demonstrates improved correlation with prognosis. Approximately 18% cases experienced restaging under the updated system. TRIAL REGISTRATION NUMBER: Not applicable.
  • Genital Tract Myeloid Sarcoma Masquerading as Abnormal Uterine Bleeding
    Seema Singhal, Swati Tomar, Saroj Rajan, Rishi Dhawan, Smita Manchanda, Sandeep Mathur, Neena Malhotra
    Indian Journal of Gynecologic Oncology, 2023
  • Adjuvant treatment in cervical, vaginal and vulvar cancer
    Neerja Bhatla, Swati Tomar, Jyoti Meena, Daya Nand Sharma, Lalit Kumar
    Best Practice and Research Clinical Obstetrics and Gynaecology, 2022
  • Hypertrophic tuberculosis of vulva — an unusual case report
    Journal of the Indian Medical Association, 2021